The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(3-(3-ethyl-4-((4-(trifluoromethyl)benzyl)oxy)phenyl)-1,2,4-oxadiazol-5yl)pyrrolidine-1-carboximidamide hydrochloride ID: ALA4466495
PubChem CID: 155531486
Max Phase: Preclinical
Molecular Formula: C23H25ClF3N5O2
Molecular Weight: 459.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl
Standard InChI: InChI=1S/C23H24F3N5O2.ClH/c1-2-15-12-16(20-29-21(33-30-20)18-4-3-11-31(18)22(27)28)7-10-19(15)32-13-14-5-8-17(9-6-14)23(24,25)26;/h5-10,12,18H,2-4,11,13H2,1H3,(H3,27,28);1H/t18-;/m0./s1
Standard InChI Key: BJUFOZWZWKQVSR-FERBBOLQSA-N
Molfile:
RDKit 2D
34 36 0 0 0 0 0 0 0 0999 V2000
17.0979 -9.4529 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.9904 -5.5891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5048 -8.5476 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.9380 -7.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7507 -3.0737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7748 -5.0521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1841 -5.7637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3552 -3.3805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2237 -8.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7325 -4.4306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4043 -5.5840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5104 -6.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5091 -7.7292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.5389 -4.2559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3685 -7.7277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2242 -8.9663 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2234 -5.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6571 -8.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0736 -4.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6517 -5.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2252 -6.9087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6533 -6.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5116 -5.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3667 -6.9067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1415 -3.6299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7956 -6.9078 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9391 -6.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9540 -4.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9416 -6.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9388 -5.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3187 -4.4357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0815 -6.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2250 -7.7259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5172 -8.1343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 1 0
21 29 2 0
29 30 1 0
12 21 1 0
26 32 1 0
2 19 1 0
23 12 2 0
25 8 1 0
15 24 1 0
11 28 2 0
10 20 2 0
28 14 1 0
9 13 1 0
7 2 1 0
20 11 1 0
4 18 1 0
6 28 1 1
19 31 1 0
4 9 1 0
17 23 1 0
12 26 1 0
31 25 1 0
18 15 2 0
30 17 2 0
9 16 1 0
22 27 1 0
32 24 1 0
24 22 2 0
30 20 1 0
14 10 1 0
31 6 1 0
9 3 1 0
25 5 2 0
27 4 2 0
21 33 1 0
33 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 459.47Molecular Weight (Monoisotopic): 459.1882AlogP: 4.93#Rotatable Bonds: 6Polar Surface Area: 101.26Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.17CX LogP: 5.70CX LogD: 3.23Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.40Np Likeness Score: -1.26
References 1. Sibley CD, Morris EA, Kharel Y, Brown AM, Huang T, Bevan DR, Lynch KR, Santos WL.. (2020) Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity., 63 (3): [PMID:31895563 ] [10.1021/acs.jmedchem.9b01508 ]